Bone flare after initiation of novel hormonal therapy in patients with metastatic hormone-sensitive prostate cancer: A case report

BACKGROUND: The 2020 European Association of Urology prostate cancer guidelines recommend androgen deprivation therapy (ADT) in combination with apalutamide and enzalutamide, a new generation of androgen receptor antagonists, as first-line therapy. A decrease in prostate-specific antigen (PSA) level...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ke-Hao, Du, Yuan-Cheng, Yang, Dong-Yu, Yu, Xin-Yuan, Zhang, Xue-Ping, Li, Yong-Xiang, Qiao, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198870/
https://www.ncbi.nlm.nih.gov/pubmed/35801020
http://dx.doi.org/10.12998/wjcc.v10.i15.4985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198870/
https://www.ncbi.nlm.nih.gov/pubmed/35801020
http://dx.doi.org/10.12998/wjcc.v10.i15.4985

Ejemplares similares